1. Home
  2. VOXR vs ABEO Comparison

VOXR vs ABEO Comparison

Compare VOXR & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vox Royalty Corp.

VOXR

Vox Royalty Corp.

HOLD

Current Price

$5.60

Market Cap

355.5M

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

N/A

Current Price

$5.48

Market Cap

399.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VOXR
ABEO
Founded
2014
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.5M
399.5M
IPO Year
2022
2005

Fundamental Metrics

Financial Performance
Metric
VOXR
ABEO
Price
$5.60
$5.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.90
$20.00
AVG Volume (30 Days)
407.2K
1.1M
Earning Date
05-08-2026
05-13-2026
Dividend Yield
1.01%
N/A
EPS Growth
N/A
165.16
EPS
N/A
N/A
Revenue
N/A
$2,998,000.00
Revenue This Year
$60.51
$1,024.31
Revenue Next Year
$44.51
$145.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
258.18
52 Week Low
$3.44
$4.00
52 Week High
$6.70
$7.65

Technical Indicators

Market Signals
Indicator
VOXR
ABEO
Relative Strength Index (RSI) 56.50 33.09
Support Level $4.81 $5.23
Resistance Level $5.86 $5.55
Average True Range (ATR) 0.20 0.21
MACD -0.02 -0.05
Stochastic Oscillator 50.00 11.88

Price Performance

Historical Comparison
VOXR
ABEO

About VOXR Vox Royalty Corp.

Vox Royalty Corp is a returns-focused mining royalty and streaming company. It holds a diversified portfolio of several royalties and streams, including producing and development stage assets, with primary exposure to gold and select industrial metals across top-tier mining jurisdictions. Vox is organized into two operating segments, consisting of acquiring and managing royalty interests; and acquiring and managing streams and other interests. Maximum revenue is generated from its Royalty Interests segment. The majority of the company's portfolio of royalty, streams, and other interests by asset count is located in Australia, Canada, and the United States, of which the maximum revenue is derived from its assets in Australia.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Share on Social Networks: